Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatment
Crossref DOI link: https://doi.org/10.1007/s00228-016-2091-4
Published Online: 2016-07-09
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hirai, Keita
Shimomura, Tatsuki
Moriwaki, Hideaki
Ishii, Hidetoshi
Shimoshikiryo, Takayuki
Tsuji, Daiki
Inoue, Kazuyuki
Kadoiri, Toshihiko
Itoh, Kunihiko
License valid from 2016-07-09